Lv4
540 积分 2023-06-25 加入
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
23天前
已完结
Long-term results of multi-antigen stimulated cell therapy-I, alone or in combination with chemotherapy, as first-line maintenance therapy in advanced sarcoma: a multicenter, phase 1 trial
1个月前
已完结
The Drug-Dosing Conundrum in Oncology - When Less Is More
1个月前
已完结
Hepatocellular Carcinoma
2个月前
已完结
Head and Neck Cancer A Review
4个月前
已完结
Head and Neck Cancer
4个月前
已关闭
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
5个月前
已完结
SYHX1901, an oral dual Janus kinase and spleen tyrosine kinase inhibitor, for moderate-to-severe plaque psoriasis: A randomized phase 2 trial
5个月前
已关闭
LBP-014 HBsAg loss and seroconversion after 16-week or 24-week AHB-137 treatment in HBeAg-negative chronic hepatitis B participants on NA therapy: results from an ongoing multicenter, randomized phase IIb study
6个月前
已完结
Targeting HBV with RNA interference: Paths to cure
6个月前
已完结
皖公网安备34019202002308
